The land of microcap stocks is not my preferred hunting ground; there are way too many hype-driven stories and way too few real diamonds in the rough to make the panning process worthwhile. Even so, ChromaDex (NASDAQ:CDXC) looks like a potential exception to the rule worthy of a closer look. I think the company's basic business strategy of pursuing high-potential ingredients for supplements and other nutritional products is a sound one. For better or worse, the pharmaceutical implications of some of these products could capture investor attention and really ignite the stock for stretches at a time.
All of that said, I won't go any further than to say this looks interesting and worthy of further investigation for...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|